For: | Jitsumura M, Kokelaar RF, Harris DA. Remission endpoints in ulcerative colitis: A systematic review. World J Meta-Anal 2017; 5(4): 85-102 [DOI: 10.13105/wjma.v5.i4.85] |
---|---|
URL: | https://www.wjgnet.com/2308-3840/full/v5/i4/85.htm |
Number | Citing Articles |
1 |
Laura F. Ouboter, Marieke C. Barnhoorn, Hein W. Verspaget, Leonie Plug, Emma S. Pool, Karoly Szuhai, Lukas J.A.C. Hawinkels, Melissa van Pel, Jaap Jan Zwaginga, Dave Roelen, Frits Koning, M. Fernanda Pascutti, Andrea E. van der Meulen – de Jong. Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis. JCI Insight 2023; 8(9) doi: 10.1172/jci.insight.167402
|
2 |
Erola Astó, Iago Méndez, Sergi Audivert, Andreu Farran-Codina, Jordi Espadaler. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis. Nutrients 2019; 11(2): 293 doi: 10.3390/nu11020293
|
3 |
Joo Kyung Kim, Jae Hee Cheon. Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study. Journal of Yeungnam Medical Science 2023; 40(1): 37 doi: 10.12701/jyms.2022.00031
|